Cargando…
A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19
Potential treatments for coronavirus disease 2019 (COVID‐19) are being investigated at unprecedented speed, and successful treatments will rapidly be used in tens or hundreds of thousands of patients. To ensure safe and effective use in all those patents it is essential also to develop, at unprecede...
Autores principales: | Peck, Richard W., Weiner, Daniel, Cook, Jack, Robert Powell, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283813/ https://www.ncbi.nlm.nih.gov/pubmed/32445484 http://dx.doi.org/10.1002/cpt.1922 |
Ejemplares similares
-
Drug Dosing Recommendations for All Patients: A Roadmap for Change
por: Powell, J. Robert, et al.
Publicado: (2020) -
Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018
por: Cook, Jack, et al.
Publicado: (2020) -
Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021) -
Optimal invasive species surveillance in the real world: practical advances from research
por: Koch, Frank H., et al.
Publicado: (2020) -
Precision Dosing: An Industry Perspective
por: Peck, Richard W.
Publicado: (2020)